WYTHES; Martin James
Patent Applications and Registrations
Patent applications and USPTO patent grants for WYTHES; Martin James.The latest application filed is for "modulators of sting (stimulator of interferon genes)".
- WYTHES; Martin James - Solana Beach CA
- Wythes; Martin James - San Diego CA
- Wythes; Martin James - Sandwich GB
| Patent | Date |
|---|---|
| Modulators of STING (Stimulator of Interferon Genes) App 20220306641 - GAJIWALA; Ketan Satish ; et al. | 2022-09-29 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20210230196 - Wythes; Martin James ; et al. | 2021-07-29 |
| Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,968,242 - Wythes , et al. April 6, 2 | 2021-04-06 |
| Modulators of STING (Stimulator of Interferon Genes) App 20210087180 - PATMAN; Ryan ; et al. | 2021-03-25 |
| Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,709,709 - Tatlock , et al. | 2020-07-14 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20200102334 - Wythes; Martin James ; et al. | 2020-04-02 |
| Substituted dihydroisoquinolinone compounds Grant 10,570,121 - Collins , et al. Feb | 2020-02-25 |
| Cyclopentane-based modulators of STING (stimulator of interferon genes) Grant 10,538,542 - Wythes , et al. Ja | 2020-01-21 |
| Substituted nucleoside derivatives useful as anticancer agents Grant 10,428,104 - Tatlock , et al. October 1, 2 | 2019-10-01 |
| Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) App 20190284216 - Wythes; Martin James ; et al. | 2019-09-19 |
| Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20190111060 - Tatlock; John Howard ; et al. | 2019-04-18 |
| Aryl and heteroaryl fused lactams Grant 10,246,433 - Edwards , et al. | 2019-04-02 |
| Substituted carbonucleoside derivatives useful as anticancer agents Grant 10,220,037 - Tatlock , et al. | 2019-03-05 |
| Substituted Dihydroisoquinolinone Compounds App 20190040047 - Collins; Michael Raymond ; et al. | 2019-02-07 |
| Substituted Carbonucleoside Derivatives Useful As Anticancer Agents App 20170348313 - Tatlock; John Howard ; et al. | 2017-12-07 |
| Substituted Dihydroisoquinolinone Compounds App 20170298048 - Collins; Michael Raymond ; et al. | 2017-10-19 |
| Aryl And Heteroaryl Fused Lactams App 20170233368 - EDWARDS; Martin Paul ; et al. | 2017-08-17 |
| Benzamide And Heterobenzamide Compounds App 20170152239 - EDWARDS; Martin Paul ; et al. | 2017-06-01 |
| Substituted Dihydroisoquinolinone Compounds App 20160376254 - COLLINS; Michael Raymond ; et al. | 2016-12-29 |
| Substituted dihydroisoquinolinone compounds Grant 9,481,666 - Kania , et al. November 1, 2 | 2016-11-01 |
| Substituted Nucleoside Derivatives Useful As Anticancer Agents App 20160244475 - Tatlock; John Howard ; et al. | 2016-08-25 |
| Substituted Dihydroisoquinolinone Compounds App 20150361067 - Collins; Michael Raymond ; et al. | 2015-12-17 |
| Benzamide And Heterobenzamide Compounds App 20150239842 - Edwards; Martin Paul ; et al. | 2015-08-27 |
| Aryl And Heteroaryl Fused Lactams App 20150175572 - EDWARDS; Martin Paul ; et al. | 2015-06-25 |
| Aryl and heteroaryl fused lactams Grant 9,040,515 - Edwards , et al. May 26, 2 | 2015-05-26 |
| Aryl And Heteroaryl Fused Lactams App 20140179667 - EDWARDS; Martin Paul ; et al. | 2014-06-26 |
| Heterocyclic compounds as inhibitors of rotomase enzymes Grant 6,610,707 - Bull , et al. August 26, 2 | 2003-08-26 |
| Method of treatment App 20030055098 - Monkhouse, Kathryn Louis ; et al. | 2003-03-20 |
| Method of treatment Grant 6,455,567 - Monkhouse , et al. September 24, 2 | 2002-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 